Hepatic Artery Chemoembolization for Hepatocellular Carcinoma in Patients Listed for Liver Transplantation
Authors:
Open Access
- 20 February 2004
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (5) , 782-787
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Liver transplantation for hepatocellular carcinoma: The MELD impactLiver Transplantation, 2004
- A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policyLiver Transplantation, 2003
- Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcomeLiver Transplantation, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting listLiver Transplantation, 2002
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Hepatic Arterial Complications in Liver Transplant Recipients Treated with Pretransplantation Chemoembolization for Hepatocellular CarcinomaRadiology, 2000
- Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?Journal of Hepatology, 1998
- Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation.Radiology, 1994